Vera Therapeutics (VERA) Treasury Shares (2020 - 2026)
Vera Therapeutics' (VERA) quarterly Treasury Shares came in at $2.1 million in Q1 2026, up 83.26% YoY from $1.2 million in Q1 2025, and up 32.38% on a QoQ basis from $1.6 million in Q4 2025.
Vera Therapeutics (VERA) Treasury Shares (2020 - 2026) Analysis & Trends
Vera Therapeutics (VERA) has 7 years of Treasury Shares data on file, last reported at $2.1 million in Q1 2026.
- Quarterly Treasury Shares rose 83.26% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 83.26% YoY) and the FY2025 annual result came in at $1.6 million, up 129.57% from the prior year.
- Treasury Shares grew to $2.1 million in Q1 2026, from $1.6 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $2.1 million in Q1 2026 to a low of $53860.0 in Q2 2022.
- A 5-year average of $654548.8 and a median of $472325.0 in 2024 frame the typical range for Treasury Shares.
- The widest YoY moves for Treasury Shares: up 5584.8% in 2022, down 99.97% in 2022.
- Tracing VERA's Treasury Shares over 5 years: stood at $204000.0 in 2022, then sank by 35.45% to $131679.0 in 2023, then surged by 429.23% to $696888.0 in 2024, then surged by 129.57% to $1.6 million in 2025, then jumped by 32.38% to $2.1 million in 2026.
- The last three Treasury Shares figures came in at $2.1 million (Q1 2026), $1.6 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Vera Therapeutics | 2.28 Bn | 2.28 Bn | - | 2.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.19 Mn |
| Jun 30, 2026 | 2.19 Mn |
| Mar 31, 2026 | 2.12 Mn |
| Mar 31, 2026 | 2.12 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.51 Mn |
| Sep 30, 2025 | 1.51 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 696,888.00 |
| Dec 31, 2024 | 696,888.00 |
| Sep 30, 2024 | 479,537.00 |
| Sep 30, 2024 | 479,537.00 |
| Jun 30, 2024 | 493,834.00 |
| Jun 30, 2024 | 493,834.00 |
| Mar 31, 2024 | 472,325.00 |
| Mar 31, 2024 | 472,325.00 |